ISB News

Symposium on “Taoism, Biology & Life” at ISB on May 18, 2015

Painting copyright Feng Xiaodong.

Institute for Systems Biology presents:

Taoism, Biology and Life

Please join ISB in welcoming Xiao Dong Feng and Dr. Stephen Little for a symposium on Taoism, Biology and Life. Opening remarks by Dr. Lee Hood. This event is free and open to the public.

Location: ISB Main Floor, 401 Terry Ave N, Seattle
Date: Monday, May 18
Time: 3:15pm – 5pm

Biographies:

Xiao Dong Feng was born in 1963 in the Anhui Province, where he learned how to paint early in his childhood. He considers painting a rich expression of life and often draws from his experience as an artist and a musician, and from having spent his formative years in the countryside as a peasant and, later on, a soldier and member of the government propaganda team. Critics describe Feng’s work as having the concise lyricism of Chinese poetry: a few simple strokes brings a scene to life.

Dr. Stephen Little initially studied nuclear physics, but changed his major to Chinese art. He received a B.A. from Cornell University in 1975, an M.A. from the University of California, Los Angeles in 1977, and a Ph.D. from Yale University in 1987. He held curatorial positions at the Asian Art Museum of San Francisco (1977–1982), the Cleveland Museum of Art (1987–1989), and the Honolulu Museum of Art (1989–1994). He held the Pritzker Curatorship of Asian Art at the Art Institute of Chicago (1995–2002), prior to becoming Director of the Honolulu Museum of Art in 2003. In 2011, Little became department head and curator of Chinese and Korean art at the Los Angeles County Museum of Art (LACMA). In his recent work he has aimed at achieving images that are spatially ambiguous, reflecting his study of nuclear physics and Daoism, the ancient Chinese system of belief that perceives reality as fluid, and teaches a way of living in balance with the natural world.

Email communications@isbscience.org if you have any questions.

 

Recent Articles

  • Co-corresponding author and ISB President Dr. Jim Heath and co-lead author Dr. Yapeng Su.

    For Cancer Cells, There Is More Than One Path to Drug Resistance

    In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.

  • ISB researchers

    Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis

    ISB researchers have unveiled new insights on how Mycobacterium tuberculosis, the pathogen that causes tuberculosis, enters and exits a dormant state in human hosts. About a quarter of the world’s population has latent TB, so these important findings will enable and accelerate the discovery of more effective TB drugs.

  • Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection

    Merck is collaborating with ISB and its partners to analyze blood samples and nasal swabs from Swedish Medical Center patients with SARS-CoV-2. Blood samples will be examined using proteomic, metabolomic, transcriptomics and genetic techniques to evaluate the impact of infection on different organs, and to identify potential biomarkers to predict the risk of severe disease.